These findings suggest the potential of having multiple beneficial effects in chronic diseases, such as diabetes mellitus and some neurodegenerative diseases, of which specific treatment includes modulation of α-glucosidase and MAO-A activity, but also nonspecific approaches for boosting organisms’ antioxidant defense. Here, MAOA is linked to diabetes mellitus.